Twinbeech Capital LP Invests $3.05 Million in HCA Healthcare, Inc. (NYSE:HCA)

Twinbeech Capital LP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 10,169 shares of the company’s stock, valued at approximately $3,052,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Galvin Gaustad & Stein LLC acquired a new position in HCA Healthcare in the 4th quarter valued at $18,044,000. Principal Financial Group Inc. grew its holdings in HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock valued at $262,264,000 after buying an additional 476,756 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. grew its holdings in HCA Healthcare by 1.6% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 120,812 shares of the company’s stock valued at $36,262,000 after buying an additional 1,931 shares in the last quarter. Hantz Financial Services Inc. grew its holdings in HCA Healthcare by 17.0% in the 4th quarter. Hantz Financial Services Inc. now owns 18,040 shares of the company’s stock valued at $5,415,000 after buying an additional 2,621 shares in the last quarter. Finally, Spire Wealth Management lifted its position in shares of HCA Healthcare by 23.0% during the 4th quarter. Spire Wealth Management now owns 9,913 shares of the company’s stock valued at $2,975,000 after acquiring an additional 1,851 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent analyst reports. Royal Bank of Canada cut their target price on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research report on Monday, April 28th. Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. StockNews.com upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, April 28th. Baird R W downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Finally, Guggenheim started coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a “neutral” rating for the company. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $381.13.

HCA Healthcare Price Performance

Shares of HCA opened at $385.95 on Wednesday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The business has a 50-day simple moving average of $343.61 and a two-hundred day simple moving average of $328.91. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a market cap of $92.85 billion, a PE ratio of 17.57, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to analysts’ expectations of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.36 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.75%. HCA Healthcare’s payout ratio is 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.